13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001596452
Total reported value
$131.7M
$131.7M
49 檔
75.2%
During the Q4 2025 filing period, Sivik Global Healthcare LLC (CIK: 0001596452) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $131.7M across 49 reported positions.
Sivik Global Healthcare LLC executed strategic sector rebalancing during Q4 2025, establishing 21 new positions while fully exiting 16 holdings and trimming 8 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 7.96% | — | -10.00% | |
| 2 | ✓ | Put - Spy 100 @ 684 Exp 01/30/2026 | Stock-Other | 5.94% | — | — | |
| 3 | ✓ | Stock-Other | 4.95% | — | — | ||
| 4 | ✓ | Put - Spy 100 @ 681 Exp 01/30/2026 | Stock-Other | 4.95% | — | — | |
| 5 | ✓ | Stock-Other | 4.95% | — | — | ||
| 6 | ✓ | Put - Spy 100 @ 679 Exp 01/30/2026 | Stock-Other | 4.95% | — | — | |
| 7 | ✓ | Stock-Other | 4.95% | — | — | ||
| 8 | ✓ | Stock-Other | 4.95% | — | — | ||
| 9 | ✓ | Put - Spy 100 @ 682 Exp 02/20/2026 | Stock-Other | 4.95% | — | — | |
| 10 | LLY | Eli Lilly & Co | Stock-Healthcare | 2.18% | — | -30.00% | |
| 11 | THC | Tenet Healthcare CORP | Stock-Healthcare | 2.16% | — | +7.14% | |
| 12 | MCK | Mckesson CORP | Stock-Healthcare | 2.14% | — | +28.57% | |
| 13 | HCA | Hca Healthcare Inc | Stock-Healthcare | 2.03% | — | -11.76% | |
| 14 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 2.02% | — | -14.29% | |
| 15 | CAH | Cardinal Health Inc | Stock-Healthcare | 1.94% | — | -13.33% | |
| 16 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.94% | — | — | |
| 17 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.81% | — | -1.64% | |
| 18 | UHS | Universal Health Services-b | Stock-Healthcare | 1.77% | — | — | |
| 19 | COR | Cencora Inc | Stock-Healthcare | 1.76% | — | -10.00% | |
| 20 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 1.64% | — | -23.08% | |
| 21 | EHC | Encompass Health CORP | Stock-Healthcare | 1.54% | — | +42.86% | |
| 22 | DHR | Danaher CORP | Stock-Healthcare | 1.53% | — | -34.29% | |
| 23 | ABT | Abbott Laboratories | Stock-Healthcare | 1.45% | — | +6.67% | |
| 24 | A | Agilent Technologies Inc | Stock-Healthcare | 1.38% | — | +6.06% | |
| 25 | ABBV | Abbvie Inc | Stock-Healthcare | 1.33% | — | — | |
| 26 | SYK | Stryker CORP | Stock-Healthcare | 1.33% | — | — | |
| 27 | MDT | Medtronic plc | Stock-Healthcare | 1.25% | — | -25.00% | |
| 28 | MTD | Mettler-toledo International | Stock-Healthcare | 1.21% | — | — | |
| 29 | SNN | Smith & Nephew PLC -spon Adr | Stock-Other | 1.19% | — | -21.88% | |
| 30 | RGEN | Repligen CORP | Stock-Healthcare | 1.19% | — | -9.09% | |
| 31 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 1.15% | — | — | |
| 32 | BDX | Becton Dickinson And Co | Stock-Healthcare | 1.13% | — | — | |
| 33 | HUM | Humana Inc | Stock-Healthcare | 1.11% | — | -40.00% | |
| 34 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 1.11% | — | — | |
| 35 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 1.07% | — | — | |
| 36 | BIO | Bio-rad Laboratories-a | Stock-Healthcare | 1.06% | — | +9.09% | |
| 37 | BIIB | Biogen Inc | Stock-Healthcare | 1.02% | — | — | |
| 38 | GMED | Globus Medical Inc - A | Stock-Healthcare | 1.01% | — | — | |
| 39 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.92% | — | — | |
| 40 | SGRY | Surgery Partners Inc | Stock-Other | 0.90% | — | -9.09% | |
| 41 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.89% | — | — | |
| 42 | BRKR | Bruker CORP | Stock-Healthcare | 0.89% | — | +8.33% | |
| 43 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.87% | — | — | |
| 44 | GEHC | GE Healthcare Technology | Stock-Healthcare | 0.83% | — | +40.00% | |
| 45 | SEM | Select Medical Holdings CORP | Stock-Other | 0.82% | — | +8.57% | |
| 46 | TECH | Bio-techne CORP | Stock-Healthcare | 0.77% | — | — | |
| 47 | CGON | Cg Oncology Inc | Stock-Other | 0.42% | — | — | |
| 48 | ARGX | Argenx Se - Adr | Stock-Healthcare | 0.37% | — | — | |
| 49 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 0.35% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | +0.7% | -10.00% | Trim |
| 2 | MCK | Mckesson CORP | +0.6% | +28.57% | Add |
| 3 | BRKR | Bruker CORP | +0.3% | +8.33% | Add |
| 4 | GEHC | GE Healthcare Technology | +0.3% | +40.00% | Add |
| 5 | EHC | Encompass Health CORP | +0.3% | +42.86% | Add |
| 6 | CAH | Cardinal Health Inc | +0.2% | -13.33% | Trim |
| 7 | VRTX | Vertex Pharmaceuticals Inc | +0.2% | -1.64% | Trim |
| 8 | SEM | Select Medical Holdings CORP | +0.2% | +8.57% | Add |
| 9 | MDT | Medtronic plc | -0.4% | -25.00% | Trim |
| 10 | DHR | Danaher CORP | -0.5% | -34.29% | Trim |
| 11 | SGRY | Surgery Partners Inc | -0.5% | -9.09% | Trim |
| 12 | SNN | Smith & Nephew PLC -spon Adr | -0.5% | -21.88% | Trim |
| 13 | HUM | Humana Inc | -0.8% | -40.00% | Trim |
| 14 | ✓ | Put - Spy 100 @ 684 Exp 01/30/2026 | — | NEW | New buy |
| 15 | ✓ | Put - Spy 100 @ 645 Exp 10/31/2025 | — | EXIT | Sold out |
| 16 | ✓ | — | NEW | New buy | |
| 17 | ✓ | Put - Spy 100 @ 679 Exp 01/30/2026 | — | NEW | New buy |
| 18 | ✓ | — | NEW | New buy | |
| 19 | ✓ | — | NEW | New buy | |
| 20 | ✓ | — | NEW | New buy | |
| 21 | ✓ | Put - Spy 100 @ 682 Exp 02/20/2026 | — | NEW | New buy |
| 22 | ✓ | Put - Spy 100 @ 681 Exp 01/30/2026 | — | NEW | New buy |
| 23 | ✓ | Put - Spy 100 @ 639 Exp 10/31/2025 | — | EXIT | Sold out |
| 24 | ✓ | Put - Spy 100 @ 659 Exp 11/21/2025 | — | EXIT | Sold out |
| 25 | ✓ | Put - Spy 100 @ 660 Exp 11/21/2025 | — | EXIT | Sold out |
| 26 | ✓ | Put - Spy 100 @ 655 Exp 10/31/2025 | — | EXIT | Sold out |
| 27 | ✓ | Put - Spy 100 @ 659 Exp 10/31/2025 | — | EXIT | Sold out |
| 28 | ✓ | Put - Spy 100 @ 660 Exp 10/31/2025 | — | EXIT | Sold out |
| 29 | ✓ | Put - Spy 100 @ 658 Exp 10/31/2025 | — | EXIT | Sold out |
| 30 | ✓ | Put - Spy 100 @ 635 Exp 10/31/2025 | — | EXIT | Sold out |
| 31 | JNJ | Johnson & Johnson | — | EXIT | Sold out |
| 32 | MTD | Mettler-toledo International | — | NEW | New buy |
| 33 | CI | THE Cigna Group | — | EXIT | Sold out |
| 34 | ZBH | Zimmer Biomet Holdings Inc | — | EXIT | Sold out |
| 35 | WST | West Pharmaceutical Services | — | EXIT | Sold out |
| 36 | BDX | Becton Dickinson And Co | — | NEW | New buy |
| 37 | NVO | Novo-nordisk A/s-spons Adr | — | NEW | New buy |
| 38 | DGX | Quest Diagnostics Inc | — | EXIT | Sold out |
| 39 | AZNN | Astrazeneca Plc-spons Adr | — | NEW | New buy |
| 40 | BIIB | Biogen Inc | — | NEW | New buy |
| 41 | GMED | Globus Medical Inc - A | — | NEW | New buy |
| 42 | MRK | Merck & Co. Inc. | — | NEW | New buy |
| 43 | GILD | Gilead Sciences Inc | — | NEW | New buy |
| 44 | EW | Edwards Lifesciences CORP | — | NEW | New buy |
| 45 | LH | Labcorp Holdings Inc | — | EXIT | Sold out |
| 46 | TECH | Bio-techne CORP | — | NEW | New buy |
| 47 | STVN | Stevanato Group S.p.A. | — | EXIT | Sold out |
| 48 | CGON | Cg Oncology Inc | — | NEW | New buy |
| 49 | ARGX | Argenx Se - Adr | — | NEW | New buy |
| 50 | ALNY | Alnylam Pharmaceuticals Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Sivik Global Healthcare LLC reported a total U.S. public equity portfolio value of $131.7M across 49 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including XBI, PUT - SPY 100 @ 684 EXP 01/30/2026, ) accounted for 75.2% of total reported equity market value during Q4 2025.
Top New Position Initiated
PUT - SPY 100 @ 684 EXP 01/30/2026
市值: $20.5M
Top Position Liquidated / Trimmed
PUT - SPY 100 @ 645 EXP 10/31/2025
前期市值: $20.0M
During Q4 2025, Sivik Global Healthcare LLC's top holdings by market value included XBI (8.0%)、PUT - SPY 100 @ 684 EXP 01/30/2026 (5.9%)、 (5.0%). The largest single position, XBI, represented 8.0% of total portfolio value.
In Q4 2025, Sivik Global Healthcare LLC made 50 total portfolio adjustments, initiating 21 new buys, adding to 5 positions, trimming 8 holdings, and fully liquidating 16 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.